This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a trifluoromethyl group and a spirocyclic system, makes it a valuable intermediate in the design of molecules targeting central nervous system (CNS) disorders. The compound's ability to enhance pharmacokinetic properties, such as metabolic stability and blood-brain barrier penetration, is leveraged in the creation of potential therapeutics for conditions like depression, anxiety, and neurodegenerative diseases. Additionally, its unique scaffold is explored in medicinal chemistry for optimizing binding affinity and selectivity toward specific biological targets, such as enzymes or receptors, contributing to the development of more effective and safer drugs.